Huntsman is appointed CEO of Vivos Therapeutics, and a UC Irvine study informs the company's focus.
3 reports, 1 independent
Updated Jul 22
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Huntsman is appointed CEO of Vivos Therapeutics, and a UC Irvine study informs the company's focus.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Huntsman takes the CEO role at Vivos Therapeutics, informed by UC Irvine research.1 source
- Vivos products gain FDA clearance and CMS approval for Medicare access.
Keep exploring
The entities involved
Coverage
Newest first; wire copies grouped- PR NewswireIgnored and Undiagnosed: Sleep Apnea Threatens Women's Cognitive Health Alzheimer's disease affects more than 6 million Americans, and emerging research identifies Obstructive Sleep Apnea (OSA) as a
- PR NewswireCPAP Is Failing Patients With OCD--Vivos Exposes the Hidden Mental Health Risk Vivos Therapeutics highlights the overlooked link between Obstructive Sleep Apnea (OSA) and mental health disorders like
- Unknown outlet